Experimental vaccine targets yeast infections
Scientists at the University of Georgia have developed a new vaccine, NXT-2, that might finally offer protection against stubborn fungal infections like vaginal yeast infections.
Tested in mice, it triggered a strong immune response against Candida albicans—the main fungus behind these problems.
Right now, there aren't any approved vaccines for fungal infections, so this is a pretty big deal.
Lowered infection levels and tissue damage in mice
NXT-2 didn't just lower infection levels and tissue damage in mice—it also protected against three major deadly fungi responsible for most fatal human cases.
If it works in people too, this could seriously improve options for fighting these hard-to-treat infections.
World's 1st-ever vaccine to prevent fungal infections
For millions of women who keep getting vaginal yeast infections (RVVC), NXT-2 could be a real breakthrough.
It might also help people with weak immune systems who have few treatment choices today.
If all goes well, this would be the world's first-ever vaccine to prevent fungal infections—potentially making life easier for many.